作者
James P Sheppard, Brian D Nicholson, Joseph Lee, Dylan McGagh, Julian Sherlock, Constantinos Koshiaris, Jason Oke, Nicholas R Jones, William Hinton, Laura Armitage, Oliver Van Hecke, Sarah Lay-Flurrie, Clare R Bankhead, Harshana Liyanage, John Williams, Filipa Ferreira, Michael D Feher, Andrew J Ashworth, Mark P Joy, Simon de Lusignan, FD Richard Hobbs
发表日期
2021/3/3
期刊
Hypertension
卷号
77
期号
3
页码范围
846-855
出版商
Lippincott Williams & Wilkins
简介
Hypertension has been identified as a risk factor for coronavirus disease 2019 (COVID-19) and associated adverse outcomes. This study examined the association between preinfection blood pressure (BP) control and COVID-19 outcomes using data from 460 general practices in England. Eligible patients were adults with hypertension who were tested or diagnosed with COVID-19. BP control was defined by the most recent BP reading within 24 months of the index date (January 1, 2020). BP was defined as controlled (<130/80 mm Hg), raised (130/80–139/89 mm Hg), stage 1 uncontrolled (140/90–159/99 mm Hg), or stage 2 uncontrolled (≥160/100 mm Hg). The primary outcome was death within 28 days of COVID-19 diagnosis. Secondary outcomes were COVID-19 diagnosis and COVID-19–related hospital admission. Multivariable logistic regression was used to examine the association between BP …
学术搜索中的文章
JP Sheppard, BD Nicholson, J Lee, D McGagh… - Hypertension, 2021